Scale -

  • Revenue is 366 Rs Cr; Annual Growth is 1389 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 659 %
  • Ebitda is -5.47 Rs Cr; Annual Decline is -296 %; in Bottom Quartile
  • PBT is -49.86 Rs Cr; Annual Decline is -297 %; Continuous Decline over 3 years; in Bottom Quartile
  • PAT is -5.49 Rs Cr; Annual Decline is -353 %; in Bottom Quartile
  • Quarterly Ebitda is N/A Rs Cr; Continuous Decline over 3 Quarters
  • Quarterly Profit is -49.86 Rs Cr; Continuous Decline over 3 Quarters; in Bottom Quartile

Profitability -

  • Quarterly Ebitda Margin is N/A %; Continuous Growth over 3 Quarters
  • PBDIT Margin is -1.49 %; Annual Decline is -113 %; in Bottom Quartile
  • PAT Margin is -1.5 %; Annual Decline is -117 %; in Bottom Quartile

Return -

  • Asset Turnover is 94 %; Annual Growth is 422 %; Continuous Growth over 3 years
  • ROCE is -1.85 %; Annual Decline is -250 %; in Bottom Quartile
  • ROA is -1.07 %; Annual Decline is -232 %; in Bottom Quartile
  • ROE is -5.65 %; Annual Decline is -368 %; in Bottom Quartile

Efficiency -

  • Operating cash flow is 1.74 Rs Cr; Annual Growth is 101 %; 5 Year CAGR is 205 %
  • Current Ratio is 1.67; Annual Decline is -62 %; 5 Year CAGR is -44 %
  • Inventory Turnover Ratio is 2.55; in Bottom Quartile
  • Quick Ratio is 1; 5 Year CAGR is -51 %

Solvancy -

  • Debt/Equity is 0; Annual Decline is -100 %; in Bottom Quartile
  • Long term Debt is 0 Rs Cr; Annual Decline is -100 %
  • Total Debt is 0 Rs Cr; Annual Decline is -100 %; in Bottom Quartile

Quality -

  • Operating cashflow/ebitda is -32 %; Annual Growth is 100 %; in Bottom Quartile
  • Operating cashflow/PAT is -32 %; Annual Growth is 100 %; in Bottom Quartile
  • Current Tax/PAT is 0 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 13 %; 5 Year CAGR is -37 %
  • Change in Inventories/Total Expenses is 0 %; Annual Growth is 100 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Welcure Drugs and Pharmaceuticals Ltd. Estimates – BSE:WELCURE
Read More
  • Past/current
Welcure Drugs & Pharmaceuticals Ltd. Shareholding Pattern – Promoters, FIIs & DIIs
Read More
  • Past/current